Lancet
The most recent articles from:
Lancet
-
Understanding the proportion of invasive cervical cancer (ICC) caused by different human papillomavirus (HPV) genotypes can inform primary (ie, vaccination) and secondary (ie, screening) prevention efforts that target specific HPV genotypes. However, using the global literature to estimate population attributable fractions (AFs) requires a methodological framework to address HPV genotype-specific causality from aggregated data. We aimed to estimate the proportion of ICC caused by different HPV genotypes at the global, regional, and national level. ⋯ EU Horizon 2020 Research and Innovation Programme.
-
Letter Randomized Controlled Trial
Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial.